Luncheon Symposium (LS) : Update on the efficacy and safety of dutasteride in the management of androgenetic alopecia
January 2015
in “프로그램북(구 초록집)”
TLDR Dutasteride is effective and safe for treating common hair loss, and it's more potent than finasteride, leading to better hair growth and thickness.
The document from 8 years ago discussed the efficacy and safety of dutasteride in managing androgenetic alopecia (AGA), the most common type of hair loss. Dutasteride, which inhibits both type 1 and 2 5α-reductase enzymes, was shown to have a potent ability to reduce scalp dihydrotestosterone (DHT), a metabolite of testosterone that contributes to hair loss. The FDA approved dutasteride in 2002 for treating benign prostatic hyperplasia, and it is also approved by the KFDA for treating AGA. Phase II studies showed a dose-dependent increase in hair growth with dutasteride, and it was found to be three times more potent than finasteride for inhibiting type 2 5α-reductase enzyme and 100 times more potent for inhibiting the type 1 enzyme. All tested doses of dutasteride and finasteride 5 mg were significantly better than placebo at 12 and 24 weeks, but only dutasteride at a 2.5 mg daily dose was statistically superior to finasteride in terms of hair counts. At 24 weeks, dutasteride 0.5mg had significantly higher hair count and width, and improved hair growth compared with finasteride and placebo. The document did not discuss the effect of combining dutasteride with minoxidil.
View this study on kiss.kstudy.com →
Related
research A Review on Finasteride: A 5-Alpha Reductase Inhibitors, its Mechanism, Facts and Benefits
research Development of finasteride polymer microspheres for systemic application in androgenic alopecia
Finasteride microspheres help reduce hair loss for up to eight weeks with fewer side effects.
research Long-term treatment with finasteride induces apoptosis and pathological changes in female mice
Finasteride causes harmful organ changes in female mice.
research FINASTERIDE AS A TREATMENT FOR MALE ANDROGENETIC ALOPECIA
research Marked Suppression of Dihydrotestosterone in Men with Benign Prostatic Hyperplasia by Dutasteride, a Dual 5α-Reductase Inhibitor
Dutasteride more effectively lowers DHT levels in men with enlarged prostates than finasteride.
research Dutasteride, a novel dual 5-A reductase inhibitor, reduces serum DHT to a greater extent versus finasteride and achieves finasteride maximal reduction in a larger proportion of patients
Dutasteride reduces DHT more effectively than finasteride.
research 5α-Reductase Inhibitors in the Treatment of Androgenetic Alopecia
Finasteride improves hair growth in men with androgenetic alopecia.
research Clinical Pharmacokinetics and Pharmacodynamics of Finasteride
Finasteride helps regrow hair and shrink prostate by reducing DHT, with some sexual side effects.
research Comparison of Finasteride (Proscar®) and Serenoa repens (Permixon®) in the Inhibition of 5-Alpha Reductase in Healthy Male Volunteers
Finasteride works better than Permixon in reducing dihydrotestosterone levels.
research Hair growth effects of oral administration of finasteride, a steroid 5 alpha-reductase inhibitor, alone and in combination with topical minoxidil in the balding stumptail macaque.
Finasteride and minoxidil together promote hair growth better than either alone.